(Q28301571)

1

0 references

Gail D Anderson

2

0 references

Joseph S Bubalo

3

0 references

Jeannine S McCune

Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression

4

0 references

language of work or name

English

0 references

publication date

December 2008

0 references

published in

Pharmacotherapy

0 references

volume

28

0 references

issue

12

0 references

page(s)

1502-10

0 references

cites work

1 reference

https://api.crossref.org/works/10.1592/PHCO.28.12.1502

Optimization of allogeneic transplant conditioning: not the time for dogma

21 April 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Hematopoietic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Convulsions due to high-dose busulphan

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Plasma concentration monitoring of busulfan: does it improve clinical outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Cellular and clinical pharmacology of fludarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

ABCC2-mediated biliary transport of 4-glutathionylcyclophosphamide and its contribution to elimination of 4-hydroxycyclophosphamide in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Transporters and their impact on drug disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Treatment of epilepsy in adults: expert opinion, 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

EFNS guideline on the diagnosis and management of alcohol-related seizures: report of an EFNS task force.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Anticonvulsant hypersensitivity syndrome: implications for pharmaceutical care

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

A mechanistic approach to antiepileptic drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Myelodysplastic syndrome associated with chronic valproic acid therapy: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Comparison of basal glutathione S-transferase activities and of the influence of phenobarbital, butylated hydroxy-anisole or 5,5'-diphenylhydantoin on enzyme activity in male rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

21 January 2018

Busulphan and phenytoin

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury: report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Comparison and predictors of rash associated with 15 antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Significant induction of cyclophosphamide and thiotepa metabolism by phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Effects of phenytoin on glutathione status and oxidative stress biomarker gene mRNA levels in cultured precision human liver slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Population pharmacokinetic analysis resulting in a tool for dose individualization of busulphan in bone marrow transplantation recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Improved outcomes in intermediate- and high-risk aggressive non-Hodgkin lymphoma after autologous hematopoietic stem cell transplantation substituting intravenous for oral busulfan in a busulfan, cyclophosphamide, and etoposide preparative regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Intravenous busulfan in adults prior to haematopoietic stem cell transplantation: a population pharmacokinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Antiepileptic treatment in paediatric oncology--an interdisciplinary challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Clobazam for seizure prophylaxis during busulfan chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics in association with early clinical outcome and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Lorazepam for seizure prophylaxis during high-dose busulfan administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharmacokinetic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Pharmacokinetic interactions of topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Postoperative seizures: epidemiology, pathology, and prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502

Clinically relevant drug interactions with antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.12.1502